Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With <i>IDH</i>-Mutant Glioma
Changho Choi(Southwestern Medical Center), Elizabeth A. Maher(Southwestern Medical Center), Keith Hulsey(VA North Texas Health Care System), Vamsidhara Vemireddy(The University of Texas Southwestern Medical Center), Dwight Oliver(The University of Texas Southwestern Medical Center), Edward Pan(VA North Texas Health Care System), Robert Bachoo(Unknown), Vivek Tiwari(VA North Texas Health Care System), Jack Raisanen(Southwestern Medical Center), James Battiste(University of Oklahoma Health Sciences Center), Sarah McNeil(Center for Neuro-Oncology), Christopher J. Madden(Center for Neuro-Oncology), Zhongxu An(VA North Texas Health Care System), Toral Patel(VA North Texas Health Care System), Sandeep Ganji(VA North Texas Health Care System), Tomoyuki Mashimo(The University of Texas Southwestern Medical Center), Craig R. Malloy(Southwestern Medical Center), Samuel Barnett(VA North Texas Health Care System), Akshay Madan(VA North Texas Health Care System), Bruce Mickey(Neurological Surgery), Christie A. Sheppard(VA North Texas Health Care System), Song Zhang(VA North Texas Health Care System), Kimmo J. Hatanpaa(Southwestern Medical Center)
Cited by 195
Related Papers
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Lactate Metabolism in Human Lung Tumors
|Cell|2017|1.3k
Malignant glioma: genetics and biology of a grave matter
|Genes & Development|2001|1.2k
Metabolic Heterogeneity in Human Lung Tumors
|Cell|2016|1.1k